Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Inari Medical (NASDAQ:NARI) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Inari Medical will report an earnings per share (EPS) of $-0.09.

Benzinga

Earnings Preview For Mirati Therapeutics

Mirati Therapeutics (NASDAQ:MRTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Mirati Therapeutics will report an earnings per share (EPS) of $-3.49.

Benzinga

How Is The Market Feeling About Lululemon Athletica?

Lululemon Athletica's (NASDAQ:LULU) short percent of float has fallen 10.36% since its last report. The company recently reported that it has 2.22 million shares sold short, which is 1.99% of all regular shares that are available for trading.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Key Takeaways From Analyst Views On Expedia Post Q1

Analysts gave mixed opinions on Expedia Group, Inc (NASDAQ: EXPE) p

Benzinga

If You Invested $100 In Sunrun 5 Years Ago, Here's How Much You Would Have Today

Sunrun (NASDAQ:RUN) has outperformed the market over the past 5 years by 24.65% on an annualized basis producing an average annual return of 36.29%. Currently, Sunrun has a market capitalization of $4.84 billion.

Benzinga

Check Out What Whales Are Doing With ABNB

A whale with a lot of money to spend has taken a noticeably bearish stance on Airbnb. Looking at options history for Airbnb (NASDAQ:ABNB) we detected 89 strange trades.

Benzinga

'The Market Is Not Satisfied Until Everybody Loses': How Expedia Stock Explains Market Conditions

Expedia Group Inc (NASDAQ: EXPE) reported better-than-expected financial results on Tuesday, but the stock still got crushed.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Mid-Afternoon Market Update: Kymera Therapeutics Drops After Q1 Results; Belite Bio Shares Spike Higher

U.S. stocks traded slightly higher toward the end of trading on Tuesday.

Benzinga

Is Trouble Ahead For Netflix's US Dominance? Another Streaming Rival Reports Q1 Gains

Shares of many streaming-related companies were dragged down after market leader Netflix Inc (NASDAQ: NFLX) reported April 19 a loss in quarterly subscribers for the first time in over 10 years.

Benzinga

Here's Why Morgan Stanley Remained Bullish On Nvidia

Morgan Stanley analyst Joseph Moore reinstated NVIDIA Corp (NASDAQ:NVDA) with an Equal-Weight and a $217 price target. The price target implies an upside of 11.9%. Moore observes that Nvidia has "differentiated" offerings in the cloud and artificial intelligence and a leading position in gaming. Moore also highlighted concerns about a slowdown in gaming and its…

Benzinga

Qualigen Takes Stake In NanoSynex To Gain Access To Next-Gen Diagnostic Platform

Qualigen Therapeutics Inc (NASDAQ:QLGN) has agreed to acquire a majority stake in NanoSynex Ltd, an Israeli-based developer of next-generation diagnostics technology. NanoSynex's Antimicrobial Susceptibility Testing (AST) platform provides rapid, accurate, and personalized tests for bacterial infections to quickly match the correct antibiotics to treat a patient's particular infection. Antibiotic misuse and overuse have given…

Benzinga

Earnings Outlook For Nephros

Nephros (NASDAQ:NEPH) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Nephros will report an earnings per share (EPS) of $-0.11.

Benzinga

Earnings Outlook For Casa Systems

Casa Systems (NASDAQ:CASA) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Casa Systems will report an earnings per share (EPS) of $-0.06.

Benzinga

Rapid7's Earnings: A Preview

Rapid7 (NASDAQ:RPD) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Rapid7 will report an earnings per share (EPS) of $-0.16.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

A Preview Of Inseego's Earnings

Inseego (NASDAQ:INSG) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Inseego will report an earnings per share (EPS) of $-0.11.

Benzinga

PDC Energy's Earnings: A Preview

PDC Energy (NASDAQ:PDCE) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that PDC Energy will report an earnings per share (EPS) of $3.09.

Benzinga

Apellis Pharmaceuticals's Earnings: A Preview

Apellis Pharmaceuticals (NASDAQ:APLS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Apellis Pharmaceuticals will report an earnings per share (EPS) of $-1.32.

Benzinga

Here's How Much You Would Have Made Owning Cassava Sciences Stock In The Last 5 Years

Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 25.46% on an annualized basis producing an average annual return of 37.25%. Currently, Cassava Sciences has a market capitalization of $844.87 million.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Earnings Outlook For NuVasive

NuVasive (NASDAQ:NUVA) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that NuVasive will report an earnings per share (EPS) of $0.39.

Benzinga

Diamondback Energy Whale Trades For May 03

Someone with a lot of money to spend has taken a bullish stance on Diamondback Energy (NASDAQ:FANG). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Apple Renews Focus On Apple Car With Latest Move, Hires Industry Veteran

Apple Inc (NASDAQ:AAPL) hired Desi Ujkashevic, a Ford Motor Company (NYSE:F) veteran who specialized in leading safety efforts and vehicle engineering, Bloomberg reports. Apple's move hints at the ramp-up of its self-driving Apple Car despite several high-profile departures over the past year. The hiring looks to fuel its sales numbers while firing up rivalry with EV…

Benzinga

12 Information Technology Stocks Moving In Tuesday's Intraday Session

Benzinga

12 Industrials Stocks Moving In Tuesday's Intraday Session

Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga

11 Financials Stocks Moving In Tuesday's Intraday Session

1 … 575 576 577 578

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Warner Bros Discovery

884 stories

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Covid-19

30,808 stories

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.